Coronavirus disease (COVID-19) was discovered in December 2019. Kenya reported its first case on the 13th of March 2020
Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, the infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death.
Standard recommendations to prevent infection spread include physical distancing, wearing a mask, keeping rooms well ventilated, avoiding crowds, cleaning your hands, and coughing into a bent elbow or tissue.
Clinical Videos for Healthcare Providers
Currently only a few treatments available help mildly ill patients – people who have COVID-19 who do not require admission to hospital. Drugs like azithromycin, bamlanivimab, colchicine, hydroxychloroquine, ivermectin, lopinavir-ritonavir,…
These consolidated guidelines for the prevention, control and management COVID-19 in Kenya provide updated recommendations for comprehensive prevention and case management strategies in Kenya. They cover infection prevention and control…
This living guideline responds to emerging evidence from randomised controlled trials (RCTs) on existing and new drug treatments for covid-19. Among these are large national and international platform trials (such as RECOVERY, WHO SOLIDARITY, and DISCOVERY).
This was a comprehensive review of the published and grey literature on the ability of hospitals in Kenya to provide emergency and critical care services and to identify priority actions for use by policymakers and other stakeholders as a roadmap toward strengthening the COVID-19 response in the country.
Patients who are assessed by a Health Care Worker and meet all the criteria below will be considered for home-based isolation and care; laboratory-confirmed COVID-19, asymptomatic patients or patients with mild symptoms of COVID-19, absence of comorbidities, and access to a suitable space for home-based isolation and care.